Why Screening Tests for Ovarian Cancer Are Not Reliable
Ovarian cancer commonly begins as a cyst made up of cancerous cells. As cancer progresses, the dangerous effects spread to other parts of the body with the cancerous cells. Medical professionals have many detection techniques in place to determine if a female has ovarian cancer, but many of these methods are unreliable. Doctors warn that “there are currently no screening tests for it that are sensitive enough to reliably screen it without a high number of inaccurate results” 
A commonly used test is known as the CA-125 test, an advanced blood test that measures the levels of the CA-125 protein. This test is not a reliable screening test because CA-125 can be elevated from other common conditions; however, it is a helpful “diagnostic tool in postmenopausal women” . In numerous cases, even though ovarian cancer was present, it was seen that the CA-125 blood test was not elevated enough. This is why the FDA recently issued a warning that stated that “women should not rely on these screening [tests] to make health or treatment decisions” .
Related Post – Detection. Ovarian Cancer Canada.
DoctorSolve Healthcare Solutions Inc., a Canadian Internet-based pharmacy intermediary (license #BC X23), offers low-cost, long-term prescription drugs. A professionally registered pharmacist fills all Canadian prescriptions. A certified member of the Canadian International Pharmacy Association, DoctorSolve is ranked as one of the best online Canadian pharmacies by Pharmacy Checker.